Specifically, they demonstrated that C/EBPβ and STAT3 were (i) responsible for MGES expression, (ii) able to reprogram neuronal stem cells towards a MES phenotype, and (iii) responsible for the aggressiveness traits of glioma cells. The gene discussed is STAT3; the disease is central nervous system cancer.